Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) saw a large decrease in short interest during the month of August. As of August 31st, there was short interest totalling 4,600 shares, a decrease of 82.4% from the August 15th total of 26,100 shares. Based on an average daily trading volume, of 220,200 shares, the days-to-cover ratio is presently 0.0 days.
OTCMKTS SNPHY traded down $0.28 during trading on Wednesday, hitting $15.23. The company had a trading volume of 13,515 shares, compared to its average volume of 54,902. Santen Pharmaceutical has a one year low of $12.50 and a one year high of $20.93. The company’s fifty day moving average is $14.40 and its 200-day moving average is $13.83.
A number of equities research analysts recently commented on SNPHY shares. Daiwa Capital Markets upgraded shares of Santen Pharmaceutical from an “underperform” rating to a “neutral” rating in a report on Wednesday, July 21st. Mizuho upgraded shares of Santen Pharmaceutical from a “neutral” rating to a “buy” rating in a report on Monday, June 7th.
Santen Pharmaceutical Co, Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the following segments: Pharmaceuticals and Others. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products.
Featured Story: Dual Listing
Receive News & Ratings for Santen Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Santen Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.